Advertisement

Advertisement

SILO Stock Latest News

Psychedelic: Helus Pharma reports FY26 financial results

The FlyPsychedelic: Helus Pharma reports FY26 financial results

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

PremiumThe Fly

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

9d ago

Psychedelic: Definium soars on study results for LSD-based depression treatment

PremiumThe Fly

Psychedelic: Definium soars on study results for LSD-based depression treatment

14d ago

Silo Pharma reports positive stability data for stress treatment SPC-15

PremiumThe Fly

Silo Pharma reports positive stability data for stress treatment SPC-15

16d ago

Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status

PremiumCompany Announcements

Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status

20d ago

Silo Pharma regains compliance with Nasdaq min bid price requirement

PremiumThe FlySilo Pharma regains compliance with Nasdaq min bid price requirement

21d ago

Silo Pharma Implements Reverse Stock Split and Restructures Capital

Company Announcements

Silo Pharma Implements Reverse Stock Split and Restructures Capital

1M ago

Silo Pharma Inc trading halted, news pending

The Fly

Silo Pharma Inc trading halted, news pending

1M ago

Silo Pharma Announces 1-for-15 Reverse Stock Split

PremiumCompany Announcements

Silo Pharma Announces 1-for-15 Reverse Stock Split

1M ago

Silo Pharma files provisional patent for ibogaine-based therapeutics

PremiumThe Fly

Silo Pharma files provisional patent for ibogaine-based therapeutics

2M ago

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

PremiumThe Fly

Psychedelic: Jefferies initiates Compass Pathways with a Buy rating

2M ago

Psychedelic: FDA awards Compass Pathways priority review voucher

PremiumThe Fly

Psychedelic: FDA awards Compass Pathways priority review voucher

2M ago

Silo Pharma expands into AI technology with Qwikagents asset purchase

PremiumThe FlySilo Pharma expands into AI technology with Qwikagents asset purchase

3M ago

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

The Fly

Psychedelic: AtaiBeckley reports publication of BPL-003 study results

3M ago

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

The Fly

Silo Pharma gets European Patent Office allowance for PTSD prevention therapy

3M ago

Silo Pharma Acquires QwikAgents Platform Using Equity

PremiumCompany Announcements

Silo Pharma Acquires QwikAgents Platform Using Equity

3M ago

Silo Pharma Announces $1 Million Stock Repurchase Program

PremiumCompany Announcements

Silo Pharma Announces $1 Million Stock Repurchase Program

5M ago

Silo Pharma announces $1M share repurchase program

PremiumThe Fly

Silo Pharma announces $1M share repurchase program

5M ago

Silo Pharma receives Notice of Allowance in Japan for SPC-15

PremiumThe Fly

Silo Pharma receives Notice of Allowance in Japan for SPC-15

5M ago

Silo Pharma executes LOI with Allucent for Phase 1 development of SPC-15

PremiumThe FlySilo Pharma executes LOI with Allucent for Phase 1 development of SPC-15

6M ago

Silo Pharma Receives Extended Nasdaq Compliance Grace Period

Company Announcements

Silo Pharma Receives Extended Nasdaq Compliance Grace Period

6M ago

Psychedelic: Clearmind reports results from first cohort in AUD trial

The Fly

Psychedelic: Clearmind reports results from first cohort in AUD trial

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >